the aid library

Filter

325

Certified African Regional professionals: Level 1 Biorisk Management

Africa Center for Disease Control and Prevention (2023) CC

The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and i ... more

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde ... d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

External Link

WHO Monographs On Selected Medicinal Plants - Volume 2

World Health Organization WHO (2007) C_WHO

• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States; • provide models to assist Member States in developing their own mono- graphs or formularies for these ... more

Download

View PDF

Diseases of Children in the Subtropics and Tropics

Paget Stanfield, Martin Brueton, Michael Chan, Michael Parkin, and Tony Waterston Jacobs Foundation (2008)

Download

View PDF

Diagnosis Prevention and Management of Cryptococcal Disease in HIV-infected Adults and Children

WHO (2011)

Download

View PDF

Dengue Guidelines For Diagnosis, Treatment, Prevention and Control
recommended

World Health Organization; TDR (2009) C_WHO

New edition

External Link

District Laboratory Practice in Tropical Countries Part-2
recommended

Cheesbrough, M. Cambridge University Press (2006) C4

External Link

Hepatology. A Clinical Textbook

Stefan Mauss, et al. Flying Publisher, Boehringer Ingelheim (2015)

Download

View PDF

Handbook For Clinical Management Of Dengue
recommended

World Health Organization WHO WHO (2012) C_WHO

Clinical management handbook

Recommendations for Inactivated Rabies Vaccine for Human Use Produced in Cell Substrates and Embryonated Eggs

WHO WHO (2005)

Oral Cholera Vaccine Use in Complex Emergencies: What next?

World Health Organization (2005)

Download

View PDF

WHO/UNICEF Strategic Plan for Polio Outbreak Response in the Middle East

The Polio Global Eradication Initiative WHO (2013)

THE SYRIAN ARAB REPUBLIC, IRAQ, JORDAN, LEBANON, TURKEY, WEST BANK AND GAZA STRIP, EGYPT

WHO recommendations on the management of diarrhoea and pneumonia in HIV-infected infants and children

World Health Organization (2010) C_WHO

To improve survival and quality of life among the 2.5 million children living with HIV, a comprehensive package of prevention, care and treatment is required. This package should include management of infections such as pneumonia, diarrhoea, malaria and ear infections, as well as common opportunisti ... more

Ebola Hemorrhagic Fever Information Packet

Centers of Disease Control CDC (2009)

Prélèvement déchantillons et envoi

Organisation Mondiale de la Santé OMS (1998)

Guideline for Management, prevention and Control of Nipah Virus Infection including Encephalitis

Directorate General of Health Services Ministry of Health & Family Welfare Government of the People’s Republic of Bangladesh (2011) C1

Download

View PDF

Malaria Operational Plan – FY 2012 ZIMBABWE

PRESIDENT’S MALARIA INITIATIVE (2012) C1

WHO guidance: Public health response to biological and chemical weapons

World Health Organization (2004) C_WHO

The message contained in this publication is clear: countries need a public health system that can respond to the deliberate release of chemical and biological agents. Regrettable though this message may be, the use of poison gas in the war between Iraq and the Islamic Republic of Iran in the 19 ... more